Neoplasms, Connective and Soft TissueRare disease
What this study is
Translational studies in cancer research can be impeded by the lack of high-quality clinical data that can be correlated with research questions. This is particularly true in the case of rare diseases, such as bone and soft tissue tumors. It is therefore the purpose of this study to create a prospective EHR-based clinical registry for individuals with bone and soft-tissue tumors.
What's being tested
- Observation
Intervention · OTHER
Study details
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Conditions
- Neoplasms, Connective and Soft Tissue · Bone Neoplasms
- Enrolling
- 1,500 people
- Starts
- 2015-07-01
- Est. completion
- 2027-12-31
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Must have a diagnosis or presumed diagnosis of bone or soft tissue tumor as defined by the WHO classification of tumors of soft tissue and bone (4th ed.)
- Patient, or his/her designated power of attorney, must be able to understand and approve of the consent to participate.
You can't join if
- Prisoners are excluded from participation in the Registry.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openOhio State University
Columbus, Ohio, United States
- Erin Fetzer · Contacterin.fetzer@osumc.edu
- David A Liebner, MD · Contact(614) 293-2886David.Liebner@osumc.edu
Recruiting
Study team
Sponsor
Ohio State University Comprehensive Cancer Center
Study ID OSU-14242
Principal investigator
David A Liebner, MD
Ohio State University
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.